Ensign Peak Advisors’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Ensign Peak Advisors’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-56,173	Closed	-$1.96M	–	1756
2024 Q1	$1.96M	Hold	56,173	–	–	﹤0.01%	932
2023 Q4	$2.13M	Hold	56,173	–	–	﹤0.01%	892
2023 Q3	$1.03M	Hold	56,173	–	–	﹤0.01%	1186
2023 Q2	$1.46M	Hold	56,173	–	–	﹤0.01%	1002
2023 Q1	$1.06M	Buy	+56,173	New	+$1.31M	﹤0.01%	1191
2022 Q4	–	Sell	-6,260	Closed	-$112K	–	2349
2022 Q3	$112K	Buy	6,260 +3,340	+114%	+$60.2K	﹤0.01%	2068
2022 Q2	$33K	Hold	2,920	–	–	﹤0.01%	2101
2022 Q1	$65K	Hold	2,920	–	–	﹤0.01%	2088
2021 Q4	$128K	Buy	+2,920	New	+$117K	﹤0.01%	2017

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Ensign Peak Advisors's INBX Position: Q2 2024 in Review

Ensign Peak Advisors sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 56,173 shares — an estimated $1.96M sold.

Ensign Peak Advisors first reported a position in INBX in Q4 2021 and held it in 9 quarters. The position peaked at $2.13M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Ensign Peak Advisors reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Ensign Peak Advisors sold 56,173 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $1.96M.
Ensign Peak Advisors first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
Ensign Peak Advisors's Inhibrx, Inc. Common Stock position peaked at $2.13M in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Ensign Peak Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.